NO996544L - Forbindelser - Google Patents
ForbindelserInfo
- Publication number
- NO996544L NO996544L NO996544A NO996544A NO996544L NO 996544 L NO996544 L NO 996544L NO 996544 A NO996544 A NO 996544A NO 996544 A NO996544 A NO 996544A NO 996544 L NO996544 L NO 996544L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- tautomers
- prophylaxis
- enantiomers
- pain
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- 206010065390 Inflammatory pain Diseases 0.000 abstract 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 abstract 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 abstract 2
- 208000027866 inflammatory disease Diseases 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Nye forbindelser av formel (I) hvor A representerer en aromatisk karbocyklisk ring eller en 5- eller 6-leddet hetero- cyklisk aromatisk ring inneholdende 1-3 heteroatomer som kan være like eller forskjellige og er valgt fra O, N og S; X representerer -(CHz)n- hvor n representerer O eller 1; og R1, R2 og R3 er som definert i beskrivelsen, og farmasøytisk akseptable salter derav, og enantiomerer og tautomerer derav. Det er også beskrevet fremgangsmåter for fremstilling av disse forbindelsene, preparater som inneholder dem og deres anvendelse i terapi. Forbindelsene er inhibitorer av nitrogenoksydsyntase og er derved spesielt nyttige i behandlingen eller profylaksen av inflammatorisk sykdom og smerte, er som definert i beskrivelsen, og farmasøytisk akseptable salter derav, og enantiomerer og tautomerer derav. Det er også beskrevet fremgangsmåter for fremstilling av disse forbindelsene, preparater som inneholder dem og deres anvendelse i terapi. Forbindelsene er inhibitorer av nitrogenoksydsyntase og er derved spesielt nyttige i behandlingen eller profylaksen av inflammatorisk sykdom og smerte.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702534A SE9702534D0 (sv) | 1997-07-01 | 1997-07-01 | Compounds |
| PCT/SE1998/001206 WO1999001455A1 (en) | 1997-07-01 | 1998-06-22 | Compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO996544D0 NO996544D0 (no) | 1999-12-29 |
| NO996544L true NO996544L (no) | 2000-02-29 |
Family
ID=20407595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO996544A NO996544L (no) | 1997-07-01 | 1999-12-29 | Forbindelser |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6083952A (no) |
| EP (1) | EP1000064A1 (no) |
| JP (1) | JP2002507987A (no) |
| KR (1) | KR20010014367A (no) |
| CN (1) | CN1268138A (no) |
| AR (1) | AR013004A1 (no) |
| AU (1) | AU729792B2 (no) |
| BR (1) | BR9810214A (no) |
| CA (1) | CA2294734A1 (no) |
| EE (1) | EE9900602A (no) |
| HU (1) | HUP0003104A3 (no) |
| ID (1) | ID25585A (no) |
| IL (1) | IL133729A0 (no) |
| IS (1) | IS5323A (no) |
| NO (1) | NO996544L (no) |
| PL (1) | PL337536A1 (no) |
| SE (1) | SE9702534D0 (no) |
| SK (1) | SK170299A3 (no) |
| TR (1) | TR199903296T2 (no) |
| WO (1) | WO1999001455A1 (no) |
| ZA (1) | ZA985326B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK12672001A3 (sk) | 1999-12-08 | 2002-04-04 | Pharmacia Corporation | Zloženia inhibítora cyklooxygenázy-2 s rýchlym nástupom terapeutického účinku |
| JP2002073760A (ja) * | 2000-08-28 | 2002-03-12 | Tadakatsu Yoshida | 貿易統合システム |
| AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
| AU2003213266A1 (en) * | 2002-03-06 | 2003-09-22 | Smithkline Beecham Corporation | Condensed heterocyclic compounds as calcitonin agonists |
| US20040063751A1 (en) * | 2002-05-31 | 2004-04-01 | Pharmacia Corporation | Combination therapy for the treatment of amyotrophic lateral sclerosis (ALS) with cyclooxygenase-2 (COX-2) inhibitor(s) and a second drug |
| CN112225662A (zh) * | 2020-11-16 | 2021-01-15 | 苏州华鑫医药科技有限公司 | 一种邻碘苯甲酸的制备方法 |
| IL305573A (en) | 2021-03-15 | 2023-10-01 | Saul Yedgar | HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES |
| CN114773316B (zh) * | 2022-06-17 | 2022-10-25 | 上海睿跃生物科技有限公司 | 2-(2,6-二氧代-哌啶-3-基)-5-氟-异吲哚-1,3-二酮的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3761480A (en) * | 1968-07-10 | 1973-09-25 | Pennwalt Corp | Process for the preparation of 3-aryl-6-sulfamyl-7-halo-1,2,3,4-tetrahydro-4-quinazolinones |
| AU704133B2 (en) * | 1995-10-17 | 1999-04-15 | Astrazeneca Ab | Pharmaceutically active quinazoline compounds |
-
1997
- 1997-07-01 SE SE9702534A patent/SE9702534D0/xx unknown
-
1998
- 1998-06-18 ZA ZA985326A patent/ZA985326B/xx unknown
- 1998-06-18 AR ARP980102919A patent/AR013004A1/es unknown
- 1998-06-22 EP EP98931170A patent/EP1000064A1/en not_active Ceased
- 1998-06-22 PL PL98337536A patent/PL337536A1/xx unknown
- 1998-06-22 US US09/125,174 patent/US6083952A/en not_active Expired - Fee Related
- 1998-06-22 WO PCT/SE1998/001206 patent/WO1999001455A1/en not_active Application Discontinuation
- 1998-06-22 JP JP50700699A patent/JP2002507987A/ja active Pending
- 1998-06-22 HU HU0003104A patent/HUP0003104A3/hu unknown
- 1998-06-22 CA CA002294734A patent/CA2294734A1/en not_active Abandoned
- 1998-06-22 ID IDW991642A patent/ID25585A/id unknown
- 1998-06-22 EE EEP199900602A patent/EE9900602A/xx unknown
- 1998-06-22 BR BR9810214-1A patent/BR9810214A/pt not_active IP Right Cessation
- 1998-06-22 TR TR1999/03296T patent/TR199903296T2/xx unknown
- 1998-06-22 SK SK1702-99A patent/SK170299A3/sk unknown
- 1998-06-22 CN CN98808429A patent/CN1268138A/zh active Pending
- 1998-06-22 AU AU81356/98A patent/AU729792B2/en not_active Ceased
- 1998-06-22 KR KR1019997012524A patent/KR20010014367A/ko not_active Application Discontinuation
- 1998-06-22 IL IL13372998A patent/IL133729A0/xx unknown
-
1999
- 1999-12-28 IS IS5323A patent/IS5323A/is unknown
- 1999-12-29 NO NO996544A patent/NO996544L/no not_active Application Discontinuation
-
2000
- 2000-05-31 US US09/583,775 patent/US6211189B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0003104A3 (en) | 2002-01-28 |
| AU729792B2 (en) | 2001-02-08 |
| SK170299A3 (en) | 2000-08-14 |
| SE9702534D0 (sv) | 1997-07-01 |
| HUP0003104A2 (hu) | 2001-02-28 |
| US6083952A (en) | 2000-07-04 |
| BR9810214A (pt) | 2000-08-08 |
| NO996544D0 (no) | 1999-12-29 |
| US6211189B1 (en) | 2001-04-03 |
| EP1000064A1 (en) | 2000-05-17 |
| EE9900602A (et) | 2000-08-15 |
| AU8135698A (en) | 1999-01-25 |
| JP2002507987A (ja) | 2002-03-12 |
| CA2294734A1 (en) | 1999-01-14 |
| PL337536A1 (en) | 2000-08-28 |
| AR013004A1 (es) | 2000-11-22 |
| ZA985326B (en) | 1999-03-23 |
| ID25585A (id) | 2000-10-19 |
| CN1268138A (zh) | 2000-09-27 |
| KR20010014367A (ko) | 2001-02-26 |
| IS5323A (is) | 1999-12-28 |
| WO1999001455A1 (en) | 1999-01-14 |
| IL133729A0 (en) | 2001-04-30 |
| TR199903296T2 (en) | 2000-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO994900L (no) | Forbindelser | |
| NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| HUP0004559A1 (hu) | Ciklinfüggő kinázok aminotiazol inhibitorai, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| NO20025821L (no) | 2-aminokarbonyl-9H-purinderivater | |
| NO20075059L (no) | Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase | |
| AU2003301020A1 (en) | Isoquinolinone derivatives and their use as therapeutic agents | |
| NO20061839L (no) | Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav | |
| NO324228B1 (no) | 4-amino-5-cyano-2-anilino-pyrimidinderivater og deres anvendelse og fremgangsmate for fremstilling, samt farmasoytisk sammensetning | |
| NO20025601L (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
| HUP0301120A2 (hu) | Szubsztituált fenilamino-kinazolin-származékok, alkalmazásuk rendellenes sejtnövekedés kezelésére és azokat tartalmazó gyógyszerkészítmények | |
| EE200200148A (et) | Kinasoliini derivaadid, nende valmistamise meetodning kasutamine | |
| MXPA03010142A (es) | Nuevos derivados de arilheteroalquilamina. | |
| SE9803518D0 (sv) | Novel compounds | |
| NO20061789L (no) | Aminopyridinderivater som induserbare NO-syntaseinhibitorer | |
| NO324229B1 (no) | 2-hydroksymutilinkarbamat-derivater, anvendelse derav, farmasoytisk sammensetning samt fremgangsmate for fremstilling av en slik forbindelse | |
| CA2238875A1 (en) | Tri-aryl ethane derivatives as pde iv inhibitors | |
| IL163625A0 (en) | Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same | |
| WO2003082861A3 (en) | Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases | |
| NO20052182L (no) | Nye forbindelser | |
| NO996544L (no) | Forbindelser | |
| SE9803773D0 (sv) | Compounds | |
| SE0302756D0 (sv) | Novel Compounds | |
| NO982072L (no) | Amidin- og isotioureaderivater som inhibitorer av nitrogenoksydsyntase | |
| NO20022123L (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |